Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.6750
+0.0290 (4.49%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $48.08 million as of April 17, 2025. Its market cap has decreased by -50.94% in one year.
Market Cap
48.08M
Enterprise Value
51.88M
1-Year Change
-50.94%
Ranking
Category
Stock Price
0.68
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has decreased from $90.21M to $48.08M, a decrease of -46.71%. That is a compound annual growth rate of -23.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 48.08M | -41.57% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.22B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.41B |
| AbbVie | 306.03B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 224.94B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |